Current status:
Cancelled Post Market
Current status date:
2000-08-02
Product name:
TAZOCIN PWS IV 4G PIPERACILLIN-.5G TAZOBAC.
DIN:
02083612
Electronic product monograph is not available
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS):
See footnote 3
08:12.16.16
Anatomical Therapeutic Chemical (ATC):
See footnote 4
J01CR05 PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
PIPERACILLIN (PIPERACILLIN SODIUM)
|
4 G / VIAL
|
TAZOBACTAM (TAZOBACTAM SODIUM)
|
500 MG / VIAL
|